P
Puro New Zealand
Cultivator of premium medicinal cannabis
About Puro New Zealand
Puro New Zealand, established in 2018, is a significant cultivator of premium medicinal cannabis, operating two sites in the Marlborough region of New Zealand's South Island. The company was co-founded by Tim Aldridge, the Managing Director, Sank Macfarlane, the CEO, and Tom Forrest, the Cultivation Director. Macfarlane's family has farmed the land at one of the company's sites in Kēkerengū for five generations, providing deep agricultural knowledge. His background is in agri-business and corporate banking. Aldridge contributes extensive start-up experience, having established several diverse businesses, focusing on strategy and market positioning. Forrest, a recipient of the Churchill Fellowship for Cannabis Agronomy, brings international expertise in cannabis cultivation, having studied numerous commercial operations globally.
Puro operates on a business-to-business model, cultivating and supplying high-quality, pharmaceutical-grade cannabis flower and biomass to licensed pharmaceutical companies and manufacturers both in New Zealand and internationally, particularly in Australia and Europe. Revenue is generated through these bulk supply agreements. A landmark achievement was the signing of a £7 million ($16 million NZD) distribution deal with UK-based IPS Pharma, reported to be the world's largest for organic medicinal cannabis. The company has also secured a five-year supply agreement with Helius Therapeutics. Due to domestic regulatory hurdles concerning packaging, Puro has focused significantly on export markets, sending bulk products to Australia for processing and packaging before they are sold in international markets.
The company's core offering is its premium medicinal cannabis, with a strong emphasis on organic and sustainable cultivation. Its Kēkerengū coastal farm is BioGro-certified organic, a distinction held by few large-scale cannabis operations worldwide. This site benefits from a unique microclimate with high sunshine hours and coastal salt air that helps naturally manage pests. The second site, in the Waihopai Valley, houses advanced research, breeding programs, and indoor growing facilities. Puro cultivates a range of cannabis varieties, including those high in CBD, CBG, and THC, to meet diverse client needs. The company has developed a seven-stage live drying process designed to preserve the plant's therapeutic compounds and terpene profiles. Full traceability from seed to harvest is maintained, with third-party lab testing to ensure product quality and consistency meet stringent pharmaceutical standards.
Puro has a notable history of successful capital raising, beginning with a record-breaking equity crowdfunding campaign on PledgeMe in 2019 that raised $4 million. This was followed by another $2 million crowdfunding raise in 2021. In a significant vote of confidence, the company was awarded a $13 million government grant in 2022, part of a $32 million project with private funding, to develop a 'playbook' for organic cannabis production to benefit the entire New Zealand industry. The company has also formed a strategic partnership with Te Rūnanga o Kaikōura, involving an equity share and collaboration on training and potential contract growing models.
Source: Dealroom company dataNews
Open roles
Puro New Zealand in the Kaikōura District ecosystem
The Puro New Zealand office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Puro New Zealand on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Puro New Zealand on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


